ESG3 Sept 2026, 03:03 pm
Akums Drugs Receives ESG Rating of 65
AI Summary
Akums Drugs and Pharmaceuticals Ltd has been assigned an ESG rating of '65' for the Financial Year 2025-26 by NSE Sustainability Ratings & Analytics Limited. The rating was voluntarily assigned by NSE Sustainability based on publicly available information, and Akums Drugs did not engage their services for this rating. This disclosure is made pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has provided a link for investors to access the detailed ESG rating report.
Key Highlights
- Akums Drugs received an ESG rating of 65 for FY 2025-26.
- The rating was assigned by NSE Sustainability Ratings & Analytics Limited.
- The rating was voluntarily assigned based on public information.
- The company did not engage NSE Sustainability for the rating.
- Disclosure made as per SEBI regulations.
Price Impact
More from AKUMS